Full View

Minimal residual disease diagnostics and chimerism in the post‐transplant period in acute myeloid leukemia

U Bacher, T Haferlach, B Fehse… - The Scientific World …, 2011 - Wiley Online Library
In acute myeloid leukemia (AML), the selection of poor‐risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …
被引用次数：42 相关文章

Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

U Bacher, T Haferlach, B Fehse, S Schnittger… - …, 2011 - europepmc.org
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …

Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia

U Bacher, T Haferlach, B Fehse, S Schnittger… - The Scientific World …, 2011 - go.gale.com
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …
[PDF] academia.edu

[PDF][PDF] Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

U Bacher, T Haferlach, B Fehse… - …, 2011 - academia.edu
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high posttransplant …

Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

U Bacher, T Haferlach, B Fehse, S Schnittger… - The Scientific World …, 2011 - cir.nii.ac.jp
抄録< jats: p> In acute myeloid leukemia (AML), the selection of poor-risk patients for
allogeneic hematopoietic stem cell transplantation (HSCT) is associated with rather high …

Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

U Bacher, T Haferlach, B Fehse… - The Scientific World …, 2011 - ncbi.nlm.nih.gov
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …

Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia

U Bacher, T Haferlach, B Fehse… - …, 2011 - pubmed.ncbi.nlm.nih.gov
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …
[PDF] semanticscholar.org

[PDF][PDF] Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

U Bacher, T Haferlach, B Fehse… - …, 2011 - pdfs.semanticscholar.org
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high posttransplant …
[PDF] core.ac.uk

[PDF][PDF] Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

U Bacher, T Haferlach, B Fehse, S Schnittger… - …, 2011 - core.ac.uk
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high posttransplant …
[PDF] academia.edu

[PDF][PDF] Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

U Bacher, T Haferlach, B Fehse… - …, 2011 - academia.edu
In acute myeloid leukemia (AML), the selection of poor-risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high posttransplant …